Effect of KAI1/CD82 on the β1 integrin maturation in highly migratory carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 703-708

  Jee, Bo Keun ^a   Lee, Joo Yong ^a   Lim, Young ^b   Lee, Kweon Haeng ^a   Jo, Yang Hyeok ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cell migration; H1299; Integrin 1; Integrin maturation; KAI1 CD82; Tumor suppressor

Indexed keywords

BETA1 INTEGRIN; CD82 ANTIGEN; SMALL INTERFERING RNA;

ANALYTIC METHOD; ARTICLE; BIOTINYLATION; CARCINOMA CELL; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; WOUND HEALING;

ANIMALS; ANTIGENS, CD29; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; KANGAI-1 PROTEIN; LUNG NEOPLASMS; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, SMALL INTERFERING;

EID: 34250188118     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.159     Document Type: Article

References (31)

1. Gaugitsch H.W., Hofer E., Huber N.E., Schnabl E., and Baumruker T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur. J. Immunol. 21 (1991) 377-383
2. Dong J.T., Isaacs W.B., Barrett J.C., and Isaacs J.T. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 41 (1997) 25-32
3. Liu W.M., and Zhang X.A. KAI1/CD82, a tumor metastasis suppressor. Cancer Lett. 240 (2006) 183-194
4. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., and Barrett J.C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268 (1995) 884-886
5. Adachi M., Taki T., Ieki Y., Huang C.L., Higashiyama M., and Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 56 (1996) 1751-1755
6. Dong J.T., Suzuki H., Pin S.S., Bova G.S., Schalken J.A., Isaacs W.B., Barrett J.C., and Isaacs J.T. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56 (1996) 4387-4390
7. Guo X., Friess H., Graber H.U., Kashiwagi M., Zimmermann A., Korc M., and Buchler M.W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 56 (1996) 4876-4880
8. Ueda T., Ichikawa T., Tamaru J., Mikata A., Akakura K., Akimoto S., Imai T., Yoshie O., Shiraishi T., Yatani R., Ito H., and Shimazaki J. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am. J. Pathol. 149 (1996) 1435-1440
9. Yu Y., Yang J.L., Markovic B., Jackson P., Yardley G., Barrett J., and Russell P.J. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin. Cancer Res. 3 (1997) 1045-1049
10. Yang X., Wei L., Tang C., Slack R., Montgomery E., and Lippman M. KAI1 protein is down-regulated during the progression of human breast cancer. Clin. Cancer Res. 6 (2000) 3424-3429
11. Yang X., Wei L.L., Tang C., Slack R., Mueller S., and Lippman M.E. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res. 61 (2001) 5284-5288
12. Miranti C.K., and Brugge J.S. Sensing the environment: a historical perspective on integrin signal transduction. Nat. Cell Biol. 4 (2002) E83-E90
13. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
14. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
15. Akiyama S.K., and Yamada K.M. Biosynthesis and acquisition of biological activity of the fibronectin receptor. J. Biol. Chem. 262 (1987) 17536-17542
16. De Strooper B., Van Leuven F., Carmeliet G., Van Den Berghe H., and Cassiman J.J. Cultured human fibroblasts contain a large pool of precursor beta 1-integrin but lack an intracellular pool of mature subunit. Eur. J. Biochem. 199 (1991) 25-33
17. Hemler M.E. Specific tetraspanin functions. J. Cell Biol. 155 (2001) 1103-1107
18. Ono M., Handa K., Withers D.A., and Hakomori S. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res. 59 (1999) 2335-2339
19. Lee J.H., Seo Y.W., Park S.R., Kim Y.J., and Kim K.K. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res. 63 (2003) 7247-7255
20. Iwata S., Kobayashi H., Miyake-Nishijima R., Sasaki T., Souta-Kuribara A., Nori M., Hosono O., Kawasaki H., Tanaka H., and Morimoto C. Distinctive signaling pathways through CD82 and beta1 integrins in human T cells. Eur. J. Immunol. 32 (2002) 1328-1337
21. Mannion B.A., Berditchevski F., Kraeft S.K., Chen L.B., and Hemler M.E. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J. Immunol. 157 (1996) 2039-2047
22. Sugiura T., and Berditchevski F. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146 (1999) 1375-1389
23. Shibagaki N., Hanada K., Yamashita H., Shimada S., and Hamada H. Overexpression of CD82 on human T cells enhances LFA-1/ICAM-1-mediated cell-cell adhesion: functional association between CD82 and LFA-1 in T cell activation. Eur. J. Immunol. 29 (1999) 4081-4091
24. Zhang X.A., He B., Zhou B., and Liu L. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. J. Biol. Chem. 278 (2003) 27319-27328
25. He B., Liu L., Cook G.A., Grgurevich S., Jennings L.K., and Zhang X.A. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J. Biol. Chem. 280 (2005) 3346-3354
26. Jee B.K., Park K.M., Surendran S., Lee W.K., Han C.W., Kim Y.S., and Lim Y. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem. Biophys. Res. Commun. 342 (2006) 655-661
27. Salicioni A.M., Gaultier A., Brownlee C., Cheezum M.K., and Gonias S.L. Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface. J. Biol. Chem. 279 (2004) 10005-10012
28. Bellis S.L., Newman E., and Friedman E.A. Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras. J. Cell Physiol. 181 (1999) 33-44
29. Argraves W.S., Suzuki S., Arai H., Thompson K., Pierschbacher M.D., and Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J. Cell Biol. 105 (1987) 1183-1190
30. Ignotz R.A., and Massague J. Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell 51 (1987) 189-197
31. Heino J., Ignotz R.A., Hemler M.E., Crouse C., and Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. Chem. 264 (1989) 380-388